"The Gastroenterology Center of Connecticut was founded by a group of dedicated physicians who were interested in creating an innovative and progressive medical practice devoted to providing sophisticated, state-of-the-art medical care in a warm and caring environment. The goal was to help people rather than just treat diseases and maintain the interests of patients as the primary focus of the practice."

During the past decade, Gastroenterology Center of Connecticut, PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 11 clinical trials were completed, i.e. on average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Center of Connecticut, PC" #1 sponsor was "Pfizer" with 7 trials, followed by "Millennium Pharmaceuticals, Inc." with 3 trials sponsored, "Amgen" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Mesoblast, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Center of Connecticut, PC" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Clostridium Difficile Infection" (1 trials), "Colitis, Ulcerative" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Gastroenterology Center of Connecticut, PC" in a lesser frequency.

Most popular intervention types in "Gastroenterology Center of Connecticut, PC" are "Drug" (12 trials), "Other" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "CP-690,550" (3 trials), "vedolizumab" (3 trials), "Anrukinzumab" (1 trials) and "CP690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Center of Connecticut, PC" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology Center of Connecticut, PC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Gastroenterology Center of Connecticut, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Center of Connecticut, PC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".